...ormance Tecoflex stents that save inventory, shelf...eteral Stents accommodate ureteral lengths from 22...ws the Quadra-Coil to glide over any guidewire and...provide ease of placement and patient comfort in a...
...temporary internal drainage from the ureteropelvic...is engineered for ease of placement and patient co... designed for repositioning and ease of removal. A... that when activated, attracts and holds water and...
The CMV IgM enzyme immunoassay is for the qualitative detection of antibodies to cytomegalovirus. The CMV IgM assay is primarily indicated for the detection of early or recent infection.
The Shandon Sequenza uses the Shandon Coverplate system which ensures consistency and excellent staining quality. , , ,Allows the user to perform large immunostaining runs (up to 50 slides/run
Medicine Products:(Date:11/21/2008)...d schools need to work together to stop abusive be...(HealthDay News) -- Behavior that was once dismiss...ing. , And as mounting research shows the negat...al-health professionals, schools, parents and even...mbat this threatening behavior. , "Bullying sh...
(Date:11/21/2008)... Nov. 21 During a memo...ard G. Rendell today remembered Lieutenant Governo...important partner in public service, and a tireles..., "As the first woman elected lieutenant governo...t," said Governor Rendell. "Her family and her fai...
(Date:11/21/2008)...remain cautious about future antibiotic resistance...21 (HealthDay News) -- People with moderate to sev...ay be able to reduce the frequency of exacerbation...ic, a new report says. , The study, published ...ournal of Respiratory and Critical Care Medicine ,...
(Date:11/21/2008)...., Nov. 21 New research...r a smokeless, spitless tobacco product aimed at y...ve found that RJ Reynolds, Camel Snus - touted as ...ontains surprisingly high levels of nicotine. , ...t other snuff products," said Bruce Adkins of the ...
Breaking Medicine News(10 mins):Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3...calcium to the diet may help reduce the risk of de...udy of more than 95,000 women who never had kidney...tones over the eight years of the study. Women who...ent lower risk of developing kidney stones compare...
...ary disease that affects thousands of Americans, a...rding to a new study.// Researchers identified nea... schizophrenia. The known risk factors such as soc...amily history of schizophrenia, as well as unteste...
...e higher in colder months. So if you’re worried ab...go get them checked now rather than wait till the ...a study involving about 500 otherwise healthy men ...ir cholesterol checked on a quarterly basis over t...
...ive joint disease that affects more than 21 millio...symptoms are pain, stiffness, reduced joint range ...h as getting up from a chair, walking, balance and...s. Pain-reducing medications such as acetaminophen...
Other Medicine News:(Date:11/20/2008)...REXEL International Corporation (Nasdaq: PRXL ),...der, today announced that it has opened an office ... clinical research capabilities. With the addition...oughout five important biopharmaceutical centers i...zil, Chile, and Mexico. This expansion further str...
(Date:11/19/2008)... Science Corporation,researcher, Dan Tinker, pres...nual Conference in Washington, DC this week indica...mers. The computerized brain plasticity-based,Br...hat target auditory and,language systems. The ex...ments in cognition by improving speed and accuracy...
(Date:11/19/2008)...l significance , , ISELIN, N.J., Nov. 19 /...aq: PARS ) today announced results from its Phas...E) drug delivery technology formulated with 3% Dic...r, randomized, double-blinded, placebo-controlled ...pany,s 3% Diclofenac Diethanolamine NanoEmulsion c...
(Date:11/19/2008)...Biotech scientists increasingly are applying genom...understand the effects of novel drug candidates on...neering & Biotechnology News ( GEN ). They ar...ound,s mechanism of action and eventually developi... the November 15 issue of GEN . ( http://www.gene...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 1Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 2Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 3Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 4IPC The Hospitalist Company Announces Board of Director Member Changes 14788 1IPC The Hospitalist Company Announces Board of Director Member Changes 14788 2IPC The Hospitalist Company Announces Board of Director Member Changes 14788 3IPC The Hospitalist Company Announces Board of Director Member Changes 14788 4IPC The Hospitalist Company Announces Board of Director Member Changes 14788 5IPC The Hospitalist Company Announces Board of Director Member Changes 14788 6IPC The Hospitalist Company Announces Board of Director Member Changes 14788 7IPC The Hospitalist Company Announces Board of Director Member Changes 14788 8IPC The Hospitalist Company Announces Board of Director Member Changes 14788 9IPC The Hospitalist Company Announces Board of Director Member Changes 14788 10IPC The Hospitalist Company Announces Board of Director Member Changes 14788 11IPC The Hospitalist Company Announces Board of Director Member Changes 14788 12IPC The Hospitalist Company Announces Board of Director Member Changes 14788 13IPC The Hospitalist Company Announces Board of Director Member Changes 14788 14Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A INIX BPAX GLOW LB 14786 1Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A INIX BPAX GLOW LB 14786 2Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A INIX BPAX GLOW LB 14786 3Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A INIX BPAX GLOW LB 14786 4MedCom Announces Court Rules Card Activation Technologies Patent Is Valid 14785 1MedCom Announces Court Rules Card Activation Technologies Patent Is Valid 14785 2MedCom Announces Court Rules Card Activation Technologies Patent Is Valid 14785 3...nal protection against,infection with virus types ...idate vaccine, PHILADELPHIA, June 27, 2007 /PRNews...s of a Phase III study show that,CERVARIX(R), the ...,provides up to 100 percent protection against adv...on types of human papillomavirus,types 16 and 18....
...h VELCADE, cyclophosphamide,and prednisone alive ...ire-FirstCall/ -- Millennium,Pharmaceuticals, Inc....m clinical trials of VELCADE based therapies that ...(1) (CR) rates in previously,treated multiple myel...t the prestigious 11th International Myeloma Works...
Other Medicine Technology:Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 2Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 3Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 4Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 5Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 6Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 7Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6